Reverse genetics is another strategy to identify proteins involved in the regulation of tau pathology that might serve as targets for tau therapies, and Suppressor of Tauopathy proteins (SUTs) were identified using this approach in C. elegans models that develop tau aggregates through overexpression of human mutant tau [29]. Here, MAPT is linked to tauopathy.